CClinicalTrials.gg
Status unknownNCT05694299FIXITUpdated Jan 25, 2023

Nasal Bridle Versus Nasal Patch for Fixation of Nasoenteral Feeding Tubes

An interventional study of Nasal bridle and Nasal patch in Feeding Tube Complication and Feeding Disorders, sponsored by Gelre Hospitals. Status unknown at 2 sites in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-01-25.

Sponsored by Gelre Hospitals · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Jan 2023), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 1 year 2 months after the study started (first participant enrolled Nov 2021, registered Jan 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
78
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Aim of this study is to compare fixation of nasoenteral feeding tubes using either a nasal patch or a nasal bridle in clinical patients with regard to the occurrence of tube dislocation, complications, and discomfort. 78 (2 * 39) eligible patients will be included in this randomized controlled trial. The study is executed in two general teaching hospitals in the Netherlands (Gelre Hospitals Apeldoorn and Medical Spectrum Twente).

02

Conditions studied

  • Feeding Tube Complication
  • Feeding Disorders
03

In context

Feeding and Eating Disorders

740 studies on the registry are indexed under Feeding and Eating Disorders; 159 are open to participants now.

This study's planned enrollment of 78 is close to the median of 75 across 540 interventional studies indexed under Feeding and Eating Disorders.

Browse Feeding and Eating Disorders studies →

Lead sponsor

Gelre Hospitals is the lead sponsor of 3 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • adult patient (18 years or older)
  • received a nasoenteral feeding tube while being hospitalized
  • providing written informed consent

Exclusion criteria

Exclusion Criteria:

  • contraindication for a nasal bridle (e.g., cleft lip or damaged nasal mucosa)
  • clinical need to place a nasal bridle
  • anticipated feeding nasoenteral feeding tube placement for \< 3 days
  • failure of nasoenteral feeding tube placement
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
78 participants (estimated)

Study arms

  • Experimental
    Nasal bridle

    Nasal bridle fixation after nasoenteral feeding tube placement.

    Device: Nasal bridle

  • Active comparator
    Nasal patch

    Nasal patch fixation after nasoenteral feeding tube placement.

    Other: Nasal patch

Interventions

  • DeviceNasal bridle

    Bridle Pro® Nasal Tube Retaining System (Applied Medical Technology Inc., Brecksville, OH, USA)

  • OtherNasal patch

    Regular adhesive tape for medical use.

06

What researchers measure

Primary outcomes

  1. Premature dislocation of feeding tube

    Occurrence of a first premature dislocation of the feeding tube

    Time frame: Within 14 days after initial placement of the feeding tube

Secondary outcomes

  1. Complications related to fixation of the feeding tube

    Occurence of nasal pressure ulcer (grade and location); sinusitis (running nose; nasal congestion); facial pain or pressure; dysosmia; frequent sneezing; epistaxis

    Time frame: During the 14-day period after initial placement of the feeding tube

  2. Pain experienced from the nasal fixation

    Pain scored on a visual analogue scale (VAS) with a minimum score of 0 and a maximum score of 100

    Time frame: During the 14-day period after initial placement of the feeding tube

  3. Discomfort experienced from the nasal fixation

    Discomfort scored on a visual analogue scale (VAS) with a minimum score of 0 and a maximum score of 100

    Time frame: During the 14-day period after initial placement of the feeding tube

07

Study locations

1 of 2 sites recruiting
  • Gelre Hospitals
    Apeldoorn, Netherlands
    Active, not recruiting
  • Medisch Spectrum Twente
    Enschede, Netherlands
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The IPD sharing plan has not been finished yet, scheduled for Q4 2023.

Supporting information: Study protocol, Csr

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 25, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05694299
Lead sponsor
Gelre Hospitals
Collaborators
Medisch Spectrum Twente
Responsible party
Sponsor
First posted
Jan 23, 2023
Start date
Nov 1, 2021
Primary completion
Dec 31, 2023 (estimated)
Completion
Dec 31, 2023 (estimated)
Last update
Jan 25, 2023

Study contacts

Tjard Schermer, PhD
Contact
t.schermer@gelre.nl
+31(0)655102377
Mariël Klos
principal investigator · Gelre Hospitals

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion